Astec LifeSciences Limited on April 13, 2026, unveiled a leadership reshuffle that tightens the governance and operating spine of the company. The board has approved the appointment of Arijit Mukherjee as an Additional Director and Executive Director designated as Chief Operating Officer, for a three-year term from April 13, 2026 to April 12, 2029, subject to shareholder approval. Mukherjee, who currently serves as the COO of Astec LifeSciences, will continue in that role as he takes on the executive-director mantle to drive manufacturing and enterprise-wide operations.
In a broader governance refresh, Burjis N. Godrej has stepped down as Managing Director with immediate effect to pursue deeper involvement with Godrej Agrovet Limited, the group’s parent company. The board noted and recorded his resignation and approved his appointment as an Additional Director (Non-Executive, Non-Independent) of Astec LifeSciences, also subject to shareholder approval. Godrej has been a prominent figure in the Godrej ecosystem, with recent leadership stints across the Godrej Agrovet and Astec LifeSciences groups.
The board also approved the appointment of Vishal Sharma as an Additional Director (Non-Executive, Non-Independent) and as Chairperson of the Board, effective April 13, 2026, subject to shareholder approval. Sharma presently serves as Executive Director & Chief Executive Officer (Chemicals) of Godrej Industries Limited, the ultimate holding company. Bringing 30 years of experience in specialty and process chemicals across multiple geographies, Sharma’s appointment aims to align strategic leadership with the company’s growth trajectory. Additionally, Mathew Eipe was appointed as an Additional, Non-Executive, Independent Director for a term extending to June 6, 2027, also subject to shareholder approval. Eipe has a robust history with the Godrej group, including independent directorships across several entities.
Concurrent with these appointments, Nadir Godrej relinquished the roles of Chairperson and Director, with the board noting his willingness to retire and extend his involvement in other group interests. The announcements collectively shape a board that will comprise ten directors, evenly split between five independent and five non-independent members, signaling a refreshed governance framework anchored by a new chair and a strengthened executive leadership layer.